NLRP3 and lymphoma: Significantly, they found that the NLRP3 blockade resulted in delayed tumor progression, and so, to further determine whether this attenuation in tumor growth derived from the reversal of immunosuppression, they analyzed the frequencies of immune cell populations in lymphoma-bearing mice.